Flock Feed Overlaps Watchlist Portfolio Insider Calendar Search Account

Feed
Overlap
Watch
Folio
Insider
Cal
Search
Me

Flock, smart-money disclosures made readable

Allogene Therapeutics Inc

ALLONASDAQ · US

Sign in for alerts Sign in to add to portfolio

Holders

BlackRock
13F filer
$38.3M
16,445,682 sh
as-of 30 Jun 2024Stale
Two Sigma Investments
13F filer
$13.1M
5,375,456 sh
as-of 31 Mar 2026Stale
Renaissance Technologies
13F filer
$5.2M
2,139,328 sh
as-of 31 Mar 2026Stale

Ownership

Ownership data not yet available for this security.

Disclosure timeline

REDUCEDStale
Douglas Earl Martin
Allogene Therapeutics Inc · NASDAQ
−29,697 sh · $63.0K
Filed 25 Aug 2026SEC Form 4view source
DISCLOSEDStale
Renaissance Technologies
Allogene Therapeutics Inc · NASDAQ
2,139,328 sh · $5.2M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Allogene Therapeutics Inc · NASDAQ
5,375,456 sh · $13.1M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Allogene Therapeutics Inc · NASDAQ
16,445,682 sh · $38.3M
Filed 30 Jun 2024SEC 13Fview source

Announcements

No announcements on record for this security.

ALLONASDAQ · US

Sign in for alerts Sign in to add to portfolio

Latest filing25 Aug 2026Stale

3 disclosed holders · 4 disclosures · 0 announcements

Ownership

Ownership data not yet available for this security.

Announcements

No announcements on record for this security.